Science Explorer Back to mapMap
Discussion
Researcher · University Hospital of Bern · Switzerland

Hansjakob Furrer

Hansjakob Furrer publishes mostly in Infectious Diseases, Virology and Epidemiology, on topics such as HIV/AIDS drug development and treatment, HIV Research and Treatment and HIV/AIDS Research and Interventions.

ORCID 0000-0002-1375-3146 OpenAlex
World rank
#186,973
of 7,710,434 ranked researchers
Rank in Switzerland
#3,772
of 80,918
Works
479
Citations
27k
Citations per work
57.0
h-index
82
i10-index 353Top 0.4% in Infectious Diseases
Hansjakob Furrer

What does Hansjakob Furrer research?

Hansjakob Furrer's work is mostly in Medicine (63%), Immunology and Microbiology (13%).

Health Sciences: 300 works · 62.6% of their workMedicine: 300 works · 62.6% of their workInfectious Diseases: 155 works · 32.3% of their workEpidemiology: 62 works · 12.9% of their workEmergency Medicine: 48 works · 10.1% of their workHepatology: 18 works · 3.7% of their workSurgery: 17 works · 3.6% of their workEverything else: 116 works · 24.2% of their workLife Sciences: 63 works · 13.2% of their workImmunology and Microbiology: 63 works · 13.2% of their workVirology: 63 works · 13.2% of their workTHEIR WORKHansjakob Furrer479works
Life Sciences13%Health Sciences63%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine30062.6%
  2. Everything else11624.2%
    1. Immunology and Microbiology6313.2%
  1. 1Infectious Diseases32% of their works
  2. 2Virology13% of their works
  3. 3Epidemiology13% of their works
  4. 4Emergency Medicine10% of their works
  5. 5Hepatology4% of their works
  6. 6Surgery4% of their works

Research topics

Which keywords describe Hansjakob Furrer's research?

The keywords of their largest research topics: Antiretroviral Therapy, HIV Infection, Immune Response, Drug Resistance, HIV, Vaccine, Integrase Inhibitors and Nucleoside Analogues.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 26 words, with their numbers
  1. Antiretroviral Therapy7115 topics
  2. HIV Infection3202 topics
  3. Immune Response2493 topics
  4. Drug Resistance2272 topics
  5. HIV2262 topics
  6. Vaccine2072 topics
  7. Integrase Inhibitors1891 topic
  8. Nucleoside Analogues1891 topic
  9. AIDS1691 topic
  10. Antibodies1691 topic
  11. HIV Transmission1651 topic
  12. Preexposure Prophylaxis1651 topic
  13. Epidemiology1373 topics
  14. Treatment1373 topics
  15. Cardiovascular Disease1311 topic
  16. Inflammation1311 topic
  17. Diagnosis952 topics
  18. Antiviral Therapy592 topics
  19. Pneumocystis571 topic
  20. Pneumonia571 topic
  21. Hepatitis C Virus421 topic
  22. Ribavirin421 topic
  23. Mycobacterium tuberculosis381 topic
  24. Tuberculosis381 topic
  25. Cytomegalovirus171 topic
  26. Infection171 topic

Where does Hansjakob Furrer work?

Hansjakob Furrer's main affiliation in the publication record is University Hospital of Bern, Switzerland.

How many publications and citations does Hansjakob Furrer have?

OpenAlex counts 479 works and 27,285 citations for Hansjakob Furrer, an h-index of 82, ranking #186,973 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Hansjakob Furrer

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hansjakob Furrer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.